109619 ⎘
dsDNA viruses; Details; Adenoviridae Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
PROCESS FOR T CELL EXPANSION
#2PHARMACEUTICAL COMPOSITION FOR RESISTING INFECTION WITH SARS-COV-2 OR MUTANT THEREOF, AND COMBINED DRUG THEREOF
#3IL-2 SUPERAGONISTS IN COMBINATION WITH ANTI-PD-1 ANTIBODIES
#4ADENOVIRAL VECTOR-BASED VACCINE FOR EMERGING VIRUSES
#5HEPATITIS C VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF
#6ANTI-GUCY2C VACCINES AND VACCINATION
#7VIRAL DELIVERY OF NEOANTIGENS
#8RECOMBINANT ADENOVIRUS VACCINE FOR AFRICAN SWINE FEVER AND METHOD FOR CONSTRUCTING SAME
#9ADENOVIRUS EXPRESSING IMMUNE CELL STIMULATORY RECEPTOR AGONIST(S)
#10VIRAL GENE THERAPY AS TREATMENT FOR CHOLESTEROL STORAGE DISEASE OR DISORDER
#11COMPOSITIONS AND METHODS FOR TREATING BACTERIAL DISEASE
#12METHODS OF MAKING AND USING UNIVERSAL CENTRALIZED INFLUENZA VACCINE GENES
#13SELECTIVE CELL TARGETING USING ADENOVIRUS AND CHEMICAL DIMERS
#14ADENOVIRAL VECTORS AND VACCINES THEREOF
#15METHODS AND COMPOSITIONS FOR PRODUCING AN ADENOVIRUS VECTOR FOR USE WITH MULTIPLE VACCINATIONS
#16VIRAL DELIVERY OF NEOANTIGENS
#17METHODS AND COMPOSITIONS FOR PRODUCING AN ADENOVIRUS VECTOR FOR USE WITH MULTIPLE VACCINATIONS
#18VISTA MODULATORS FOR DIAGNOSIS AND TREATMENT OF CANCER
#19REPLICATION-DEFICIENT ADENOVIRUS
#20IL-2 SUPERAGONISTS IN COMBINATION WITH ANTI-PD-1 ANTIBODIES
#21Methods of vaccine administration
#22Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#23Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#24Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#25Novel Method for Obtaining Efficient Viral Vector-Based Compositions for Vaccination or Gene Therapy
#26METHODS OF PRODUCING ADENOVIRUS
#27Hepatitis C virus immunogenic compositions and methods of use thereof
#28Subcutaneous Delivery of Adenovirus with Dual Targeting
#29Methods of making and using universal centralized influenza vaccine genes
#30ADENOVIRUS EXPRESSING IMMUNE CELL STIMULATORY RECEPTOR AGONIST(S)
#31IL-10 INHIBITION FOR VACCINES AND IMMUNOTHERAPY
#32Rapid and prolonged immunologic-therapeutic
#33NUCLEOTIDE VACCINE
#34Prime/boost immunization regimen against HIV-1 utilizing a multiepitope T cell immunogen comprising Gag, Pol, Vif, and Nef epitopes
#35Viral gene therapy as treatment for cholesterol storage disease or disorder
#36Adenoviral Polypeptide IX Increases Adenoviral Gene Therapy Vector Productivity and Infectivity
#37Rapid and prolonged immunogic therapeutic
#38Rapid and prolonged immunologic therapeutic
#39Methods of vaccine administration
#40Methods and compositions for producing an adenovirus vector for use with multiple vaccinations
#41Cell line for producing adenovirus and method of preparing the same
#42Vista modulators for diagnosis and treatment of cancer
#43Programmable Oncolytic Virus Vaccine System and Method
#44VIRAL DELIVERY OF NEOANTIGENS
#45Adenoviral Polypeptide IX Increases Adenoviral Gene Therapy Vector Productivity and Infectivity
#46Method for obtaining efficient viral vector-based compositions for vaccination or gene therapy
#47Adenovirus formulations
#48Hepatitis c virus immunogenic compositions and methods of use thereof
#49Recombinant adenovirus vectored FMDV vaccines and uses thereof
#50RAPID AND PROLONGED IMMUNOGENIC-THERAPEUTIC
#51Process for T cell expansion
#52ADENOVIRUS EXPRESSING IMMUNE CELL STIMULATORY RECEPTOR AGONIST(S)
#53Subcutaneous Delivery of Adenovirus with Dual Targeting
#54IL-2 superagonists in combination with anti-PD-1 antibodies
#55METHODS AND MATERIALS FOR PRODUCING IMMUNE RESPONSES AGAINST POLYPEPTIDES INVOLVED IN ANTIBIOTIC RESISTANCE
#56Vaccine composition and preparation method and use thereof
#57Methods and compositions for combination immunotherapy
#58Adenovirus forumations
#59Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
#60Human type 55 replication defective adenovirus vector, method for preparing same and uses thereof
#61NOVEL RECOMBINANT ADENO-ASSOCIATED VIRUS CAPSIDS CONTAINING A DESIGNED ANKYRIN REPEAT PROTEIN (DARPIN) OR FRAGMENT THEREOF
#62SELECTIVE CELL TARGETING USING ADENOVIRUS AND CHEMICAL DIMERS
#63VIRAL GENE THERAPY AS TREATMENT FOR CHOLESTEROL STORAGE DISEASE OR DISORDER
#64Biodegradable polymeric particles encapsulating an active agent, pharmaceutical compositions and uses thereof
#65Method for preparing antigen-specific cytotoxic T-cells by using activated B-cells and use thereof
#66Recombinant adenovirus vectored FMDV vaccines and uses thereof
#67CD40 ligand fusion protein vaccine
#68Replication defective adenovirus vector in vaccination
#69VISTA MODULATORS FOR DIAGNOSIS AND TREATMENT OF CANCER
#70HPV vaccines and methods of use thereof
#71Breast cancer vaccines and methods of use thereof
#72Methods and materials for producing immune responses against polypeptides involved in antibiotic resistance
#73Adenovirus Expressing Immune Cell Stimulatory Receptor Agonist(s)
#74Adenovirus isolated from titi monkeys
#75REVERSE VACCINATION THERAPY OF MULTIPLE SCLEROSIS
#76Dry formulations of vaccines that are room temperature stable
#77Adenovirus formulations
#78RECOMBINANT SEROTYPE 5 (Ad5) ADENOVIRAL VECTORS
#79Rapid and prolonged immunologic-therapeutic
#80NUCLEOTIDE VACCINE
#81Immunogenic compositions comprising silicified virus and methods of use
#82Composition of viral vectors in lecithin liposomes, preparation method and treatment methods
#83Liquid stable virus vaccines
#84Recombinant serotype 5 (Ad5) adenoviral vectors
#85Methods of vaccine administration
#86METHODS AND COMPOSITIONS FOR VIRAL VECTORED VACCINES
#87Sequential and repeated immunization with four or more vector-based HIV gene vaccines
#88PROCESS FOR T CELL EXPANSION
#89Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
#90Selective cell targeting using adenovirus and chemical dimers
#91Adenoviruses expressing heterologous tumor-associated antigens
#92Rapid and prolonged immunologic-therapeutic
#93Liquid stable virus vaccines
#94Adenovirus serotype 26 and serotype 35 filovirus vaccines
#95Mucosal adjuvant composition
#96Vaccines for inclusion body hepatitis
#97Sequential administration of a replication defective adenovirus vector in vaccination protocols
#98NANOCOATINGS FOR BIOLOGICAL MATERIALS
#99Rapid and prolonged immunologic-therapeutic
#100METHODS AND MATERIALS FOR PRODUCING IMMUNE RESPONSES AGAINST POLYPEPTIDES INVOLVED IN ANTIBIOTIC RESISTANCE
#101Vaccines for inclusion body hepatitis
#102NUCLEOTIDE VACCINE
#103Immunogenic Compositions and Methods for Treating and Preventing Animal Infections
#104Sequential administration of a replication defective adenovirus vector in vaccination protocols
#105TRANSDERMAL IMMUNE PREPARATION, METHOD FOR PRODUCTION OF THE SAME, AND TRANSDERMAL IMMUNIZATION METHOD USING THE SAME
#106METHODS OF VACCINE ADMINISTRATION
#107Vaccine For Periodontal Disease
#108Canine combination vaccines
#109Methods for generating immune responses to influenza antigens with a secretable CD40L fusion protein
#110Coronavirus-like particles comprising functionally deleted genomes
#111Vaccine for periodontal disease
#112TAA/ecdCD40L oncolytic virus